SCHEMBL18907210

SCHEMBL18907210

c1ccc(-c2nc3ccc4ccccc4c3c3c2cc(-c2cccc(-c4cc5ccccc5c5c4oc4ccc6ccccc6c45)c2)c2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP1A1 P04798 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
PAX8 Q06710 1/20 0.38
ALDH1A1 P00352 8/20 0.37
MAPT P10636 7/20 0.37
KDM4E B2RXH2 6/20 0.37
HPGD P15428 5/20 0.37
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
NPY1R P25929 1/20 0.36
NPY2R P49146 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 2/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034997 0.92 ABCG2 (0.38) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL19009704 0.88 ABCG2 (0.37) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL17034996 0.87 ABCG2 (0.39) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL18907212 0.86 CYP1A2 (0.37) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL17035082 0.85 ABCG2 (0.38) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL18907198 0.84 ABCG2 (0.37) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL18471555 0.83 ABCG2 (0.50) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL17034931 0.83 ABCG2 (0.40) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL17035043 0.83 ABCG2 (0.38) ABCG2CYP1A2CYP1A1FYNMAPK3
SCHEMBL19627934 0.82 MAPT (0.38) ABCG2CYP1A2CYP1A1FYNMAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 ABCG2 3575/4885CYP1A2 421/4885CYP1A1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.